ENZ - ENZO BIOCHEM INC
0.3138
-0.068 -21.606%
Share volume: 4,123,861
Last Updated: 04-17-2025
Healthcare/Services – Health:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.07
-0.18%
View ratios
| Fiscal Date | 10-31-2023 | 01-31-2024 | 04-30-2024 | 07-31-2024 | 10-31-2024 | 01-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 12-16-2024 | 03-13-2024 | 06-13-2024 | 12-16-2024 | 12-16-2024 | 03-17-2025 | |
| Total revenue | 7.806 M | 8.553 M | 8.022 M | 7.526 M | 6.213 M | 7.334 M | |
| Cost of revenue | 4.351 M | 4.329 M | 4.289 M | 4.306 M | 3.681 M | 0.000 | |
| Gross profit | 3.455 M | 4.224 M | 3.733 M | 3.220 M | 2.532 M | 7.334 M | |
| 22.26% | -11.62% | -13.74% | -21.37% | 189.65% | |||
| Operating expenses | 7.856 M | 5.648 M | 5.084 M | 5.777 M | 5.444 M | 5.037 M | |
| Selling general and admin | 7.007 M | 5.068 M | 4.479 M | 5.169 M | 4.882 M | 4.558 M | |
| Research and development | 849.000 K | 580.000 K | 605.000 K | 608.000 K | 562.000 K | 479.000 K | |
| Total expenses | 8.931 M | 9.977 M | 5.776 M | 5.881 M | 6.154 M | 8.936 M | |
| 11.71% | -42.11% | 1.82% | 4.64% | 45.21% | |||
| Operating income | -5.476 M | -1.424 M | -2.043 M | -2.661 M | -3.622 M | -1.602 M | |
| Ebit | -6.652 M | -1.424 M | -2.857 M | -1.893 M | -3.691 M | -1.710 M | |
| Pretax income | -5.675 M | -863.000 K | -2.131 M | -1.148 M | -3.071 M | -1.248 M | |
| -84.79% | 146.93% | -46.13% | 167.51% | -59.36% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | -3.061 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||
| Net income | -6.616 M | -3.061 M | -3.020 M | -13.381 M | -3.376 M | -1.535 M | |
| 53.73% | 1.34% | -343.08% | 74.77% | 54.53% |